Posted by Michael Wonder on 18 Dec 2021
Overall survival for oncology drugs approved for genomic indications
17 December 2021 - Drug approvals for genome-informed indications have been increasing in recent years, but it is unknown how many of them have demonstrated an improvement in overall survival.
We found 53 drugs approved for 92 unique indications from 2006 to 2020.
We found that 50 drugs (55%) approved for a genomic indication had a randomised study evaluating overall survival benefit, and of those, only 22 demonstrated an improvement in overall survival.
